Roivant Sciences Ltd. (ROIV) Financials
ROIV Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 7.3 billion | 728.1 million |
2023-09-30 | 2.1 billion | 739.9 million |
2023-06-30 | 2.1 billion | 802.5 million |
2023-03-31 | 2.4 billion | 782.0 million |
ROIV Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -210.8 million | 54.3 million |
2023-09-30 | -196.7 million | 49.3 million |
2023-06-30 | -250.3 million | 49.3 million |
2023-03-31 | -180.7 million | 25.3 million |
ROIV Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | 5.1 billion |
2023-09-30 | -331.1 million |
2023-06-30 | -327.8 million |
2023-03-31 | -60.9 million |
ROIV Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 6.7 billion | - | 57.5 million |
2023-09-30 | 1.4 billion | - | 59.5 million |
2023-06-30 | 1.4 billion | 385.1 million | 63.2 million |
2023-03-31 | 1.7 billion | 375.5 million | 65.2 million |
ROIV Shares Outstanding
ROIV Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 355000 | 123.7 million | 197.3 million | - |
2023-09-30 | 275000 | 132.0 million | 164.4 million | - |
2023-06-30 | 403000 | 125.1 million | 156.2 million | 156.2 million |
2023-03-31 | 1.6 million | 131.9 million | 125.5 million | - |
ROIV Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 37.1 million | 3.7 million |
2023-09-30 | 37.1 million | 3.3 million |
2023-06-30 | 21.6 million | 4.2 million |
2023-03-31 | 27.4 million | 4.2 million |
ROIV
Price: $11.03
52 week price:
Earnings Per Share: 5.27 USD
P/E Ratio: -7.35
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.4 million
Market Capitalization: 9.2 billion